Collateral Medical Private Limited

Collateral Medical Private Limited specializes in supplying a diverse array of medical devices aimed at enhancing patient care and supporting healthcare professionals in various clinical settings. Founded in 2010 and headquartered in Mumbai, India, Collateral Medical Private Limited operates as a supplier of medical devices. The company has conducted a total of 4 funding deals, with the most recent funding round occurring on May 10, 2023, where they raised INR 6. 697 mn through participation from Carpediem Capital.

The company's founders Nandini Shastri and Nikhilesh Tiwari have previously engaged in entrepreneurial ventures, though specific details on any earlier companies are not provided. Collateral Medical is a comprehensive supplier of medical devices, focusing on a diverse range of healthcare products designed to improve patient outcomes and support medical professionals. The company's core offerings include diagnostic equipment, such as ECG machines and pulse oximeters, as well as consumable medical supplies like test strips, catheters, and wound care products. These products are aimed at addressing various clinical needs in sectors such as chronic disease management, obstetrics and gynecology, and general healthcare practices.

The customer base comprises over 30,000 doctors and 4,000 retailers, including partnerships with 20 of the top 30 pharmaceutical companies, facilitating wide-reaching distribution across India and expanding into international markets. The company’s commitment to high-quality service is supplemented by direct supply partnerships with leading medical device manufacturers, ensuring that their products are aligned with global standards of care. In the most recent year, 2022, Collateral Medical reported revenue of INR 8,695,016. 30 and an EBITDA of INR 568,119.

20. The company generates revenue through a structured B2B model that integrates direct sales to healthcare facilities and partnerships with resellers and retailers, ensuring broad product reach including hospitals, clinics, and individual healthcare practitioners. Their flagship products, such as the OneTouch and Accu-Chek blood glucose monitoring systems, cater to both professional healthcare environments and personal use, with consumable products driving repeat purchases and fostering long-term client relationships. In May 2023, Collateral Medical Private Limited secured venture funding to support its growth strategies, including the design and launch of new medical products.

The company is actively targeting expansion into new geographic regions, focusing on both domestic and international markets. Recent funding will be utilized to enhance product development and facilitate entry into these markets, ensuring Collateral Medical is well-positioned to meet the increasing demand for medical supplies.